Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib https://t.co/7wqP0gzNRD
RT @Myeloma_Doc: Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https:/…
RT @Myeloma_Doc: Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https:/…
RT @Myeloma_Doc: Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https:/…
RT @Myeloma_Doc: Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https:/…
RT @Myeloma_Doc: Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https:/…
Novel agents can be used repeatedly in novel combinations with significant clinical benefit for pts with #myeloma: https://t.co/pK8OoPcn9k.